Table 1.
Different CpG motifs
ODN | Sequence | Predominant in vitro effects |
---|---|---|
1758 | TCTCCCAGCGTGCGCCAT | Monocyte activation; enhanced NK activity (10) |
1812 | TCTCCCAGZGTGZGCCAT | Minimal immunostimulatory effect (10) |
1643 | GAGAACGCTCGACCTTCGAT | B cell mitogen (9) |
CpG dinucleotides are underlined; Z indicates 5-methylcytosine in the control ODN with methylated CpGs, 1812. All oligonucleotides were synthesized with phosphorothioate modified backbones to improve their nuclease resistance.